Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-21-029250
Filing Date
2021-02-05
Accepted
2021-02-04 21:11:28
Documents
18

Document Format Files

Seq Description Document Type Size
1 424B4 d73834d424b4.htm 424B4 1205434
2 GRAPHIC g73834g07a55.jpg GRAPHIC 80415
3 GRAPHIC g73834g07o29.jpg GRAPHIC 73781
4 GRAPHIC g73834g09h54.jpg GRAPHIC 86046
5 GRAPHIC g73834g10z25.jpg GRAPHIC 88388
6 GRAPHIC g73834g13v22.jpg GRAPHIC 81154
7 GRAPHIC g73834g28j72.jpg GRAPHIC 86903
8 GRAPHIC g73834g37d24.jpg GRAPHIC 132098
9 GRAPHIC g73834g40f39.jpg GRAPHIC 75423
10 GRAPHIC g73834g49g72.jpg GRAPHIC 68985
11 GRAPHIC g73834g61p50.jpg GRAPHIC 112130
12 GRAPHIC g73834g66c77.jpg GRAPHIC 71014
13 GRAPHIC g73834g66o99.jpg GRAPHIC 37125
14 GRAPHIC g73834g67r59.jpg GRAPHIC 73920
15 GRAPHIC g73834g68v82.jpg GRAPHIC 97123
16 GRAPHIC g73834g74u43.jpg GRAPHIC 88357
17 GRAPHIC g73834g85r24.jpg GRAPHIC 92072
18 GRAPHIC g73834g99r81.jpg GRAPHIC 119928
  Complete submission text file 0001193125-21-029250.txt   3226152
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-252613 | Film No.: 21593057
SIC: 2836 Biological Products, (No Diagnostic Substances)